Gene · 4055
Papers3,299
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,299
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| DNA Methylation and Prospects for Predicting the Therapeutic Effect of Neoadjuvant Chemotherapy for Triple-Negative and Luminal B Breast Cancer. | Cancers (Basel) | 2023 | 36900421 | PubTator, text mining | PubMed |
| Transcriptional Regulation during Aberrant Activation of NF-κB Signalling in Cancer. | Cells | 2023 | 36899924 | PubTator, text mining | PubMed |
| Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction (PENTOS-PCI). | Naunyn Schmiedebergs Arch Pharmacol | 2023 | 36856810 | PubTator, text mining | PubMed |
| The Roles of TRAF3 in Immune Responses. | Dis Markers | 2023 | 36845015 | PubTator, text mining | PubMed |
| Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies. | Pharmaceutics | 2023 | 36840015 | PubTator, text mining | PubMed |
| HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa. | Pharmaceutics | 2023 | 36839941 | PubTator, text mining | PubMed |
| Blood-Based Biomarkers for Eosinophilic Esophagitis and Concomitant Atopic Diseases: A Look into the Potential of Extracellular Vesicles. | Int J Mol Sci | 2023 | 36835081 | PubTator, text mining | PubMed |
| The Prognostic Value of Pentraxin-3 in COVID-19 Patients: A Systematic Review and Meta-Analysis of Mortality Incidence. | Int J Mol Sci | 2023 | 36834949 | PubTator, text mining | PubMed |
| Complementing Testicular Immune Regulation: The Relationship between Sertoli Cells, Complement, and the Immune Response. | Int J Mol Sci | 2023 | 36834786 | PubTator, text mining | PubMed |
| The Genetics of Primary Biliary Cholangitis: A GWAS and Post-GWAS Update. | Genes (Basel) | 2023 | 36833332 | PubTator, text mining | PubMed |
| Cannabinoid Mixture Affects the Fate and Functions of B Cells through the Modulation of the Caspase and MAP Kinase Pathways. | Cells | 2023 | 36831255 | PubTator, text mining | PubMed |
| Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8+ T cells. | Mol Oncol | 2023 | 36825382 | PubTator, text mining | PubMed |
| Specialized pro-resolving lipid mediators regulate inflammatory macrophages: A paradigm shift from antibiotics to immunotherapy for mitigating COVID-19 pandemic. | Front Mol Biosci | 2023 | 36825200 | PubTator, text mining | PubMed |
| Single-cell pair-wise relationships untangled by composite embedding model. | iScience | 2023 | 36824286 | PubTator, text mining | PubMed |
| Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas. | World J Surg Oncol | 2023 | 36823639 | PubTator, text mining | PubMed |
| Landscape of costimulatory molecule signature in breast cancer and its prognostic significance. | Ann Transl Med | 2023 | 36819560 | PubTator, text mining | PubMed |
| Progress in salivary glands: Endocrine glands with immune functions. | Front Endocrinol (Lausanne) | 2023 | 36817607 | PubTator, text mining | PubMed |
| The impact of stress and anesthesia on animal models of infectious disease. | Front Vet Sci | 2023 | 36816193 | PubTator, text mining | PubMed |
| Mycobacterium bovis BCG increase the selected determinants of monocyte/macrophage activity, which were diminished in response to gastric pathogen Helicobacter pylori. | Sci Rep | 2023 | 36813949 | PubTator, text mining | PubMed |
| Metagenomic and single-cell RNA-Seq survey of the Helicobacter pylori-infected stomach in asymptomatic individuals. | JCI Insight | 2023 | 36810249 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4055/papers?page=16